90 related articles for article (PubMed ID: 11041462)
1. Development of overt autoimmune hyperthyroidism in a patient therapeutically immunosuppressed after liver transplantation.
Khovidhunkit W; Greenspan FS; Jaume JC
Thyroid; 2000 Sep; 10(9):829-32. PubMed ID: 11041462
[TBL] [Abstract][Full Text] [Related]
2. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease].
Chen W; Man N; Li YS; Shan ZY; Teng WP
Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113
[TBL] [Abstract][Full Text] [Related]
3. Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.
Wortsman J; McConnachie P; Tahara K; Kohn LD
J Clin Endocrinol Metab; 1998 Jul; 83(7):2302-8. PubMed ID: 9661599
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease: diagnostic and therapeutic challenges (multimedia activity).
Kahaly GJ; Grebe SK; Lupo MA; McDonald N; Sipos JA
Am J Med; 2011 Jun; 124(6):S2-3. PubMed ID: 21605717
[TBL] [Abstract][Full Text] [Related]
5. Graves' disease in a renal transplant.
Suher M; Koc E; Ensari C; Oztugut SU
J Nephrol; 2004; 17(5):736-8. PubMed ID: 15593043
[TBL] [Abstract][Full Text] [Related]
6. Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients.
Jubault V; Penfornis A; Schillo F; Hoen B; Izembart M; Timsit J; Kazatchkine MD; Gilquin J; Viard JP
J Clin Endocrinol Metab; 2000 Nov; 85(11):4254-7. PubMed ID: 11095463
[TBL] [Abstract][Full Text] [Related]
7. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
8. Exacerbation of erythropoietic protoporphyria by hyperthyroidism.
Minder EI; Haldemann AR; Schneider-Yin X
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S465-9. PubMed ID: 21069463
[TBL] [Abstract][Full Text] [Related]
9. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
10. [Significance of combining tests of thyroid autoantibodies in differential diagnosis between Graves's disease and Hashimoto's hyperthyroidism].
Hu YM; Liu W; Lu GH
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):940-2. PubMed ID: 12899792
[TBL] [Abstract][Full Text] [Related]
11. Remission of Graves' hyperthyroidism predicted by smooth decreases of thyroid-stimulating antibody and thyrotropin-binding inhibitor immunoglobulin during antithyroid drug treatment.
Takasu N; Yamashiro K; Komiya I; Ochi Y; Sato Y; Nagata A
Thyroid; 2000 Oct; 10(10):891-6. PubMed ID: 11081255
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles.
Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T
Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951
[TBL] [Abstract][Full Text] [Related]
13. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
14. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
15. Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome.
Murakami Y; Takamatsu J; Sakane S; Kuma K; Ohsawa N
J Clin Endocrinol Metab; 1996 Sep; 81(9):3257-60. PubMed ID: 8784079
[TBL] [Abstract][Full Text] [Related]
16. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
[TBL] [Abstract][Full Text] [Related]
17. A case of autoimmune hepatitis combined with Graves' disease.
Jhee JH; Kim HJ; Kang W; Kim S; Kim DY
Korean J Gastroenterol; 2015 Jan; 65(1):48-51. PubMed ID: 25603854
[TBL] [Abstract][Full Text] [Related]
18. Differences between changes in serum thyrotropin-binding inhibitory antibodies and thyroid-stimulating antibodies in the course of antithyroid drug therapy for Graves' disease.
Yamano Y; Takamatsu J; Sakane S; Hirai K; Kuma K; Ohsawa N
Thyroid; 1999 Aug; 9(8):769-73. PubMed ID: 10482368
[TBL] [Abstract][Full Text] [Related]
19. Enhanced thyroid iodine metabolism in patients with triiodothyronine-predominant Graves' disease.
Takamatsu J; Hosoya T; Naito N; Yoshimura H; Kohno Y; Tarutani O; Kuma K; Sakane S; Takeda K; Mozai T
J Clin Endocrinol Metab; 1988 Jan; 66(1):147-52. PubMed ID: 3335601
[TBL] [Abstract][Full Text] [Related]
20. Disseminated thyroid autonomy or Graves' disease: reevaluation by a second generation TSH receptor antibody assay.
Meller J; Jauho A; Hüfner M; Gratz S; Becker W
Thyroid; 2000 Dec; 10(12):1073-9. PubMed ID: 11201852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
